Atlas FDA

Restylane Injectable Gels

FDA premarket approval P040024/S102 · decided 2018-08-02

Approval details

PMA number
P040024
Supplement
S102
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Restylane Injectable Gels
Generic name
Implant, dermal, for aesthetic use
Applicant
Q-Med AB
Date received
2018-07-06
Decision date
2018-08-02
Days to decision
27 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Uppsala
Statement
Change in supplier for the "puck press" used in manufacturing of Restylane Injectable Gels (Restylane, Restylane-L,Perlane, Restylane Lyft with Lidocaine, and Restylane Silk).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.